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Summary 
Background and purpose. T cells may play a role in the evolution of ischaemic damage and 
repair but the ability to image these cells in the living brain after stroke has been limited. We 
aim to extend the technique of real time in situ brain imaging of T cells, previously shown in 
models of immunological diseases, to models of experimental stroke. 
Experimental approach. Male C57BL6 mice (6-8 weeks) (n=3) received a total of 2-5 X 10
6
 
CFSE-labelled lymphocytes from donor C57BL6 mice via i.v. injection by adoptive transfer. 
Twenty four hours later, recipient mice underwent permanent left distal middle cerebral artery 
occlusion by electrocoagulation or sham surgery under isoflurane anaesthesia. Female hCD2-
GFP transgenic mice that exhibit GFP-labelled T cells underwent MCAO. At 24 or 48 hours 
post-MCAO, a sagittal brain slice (1500 µm thick) containing cortical branches of the 
occluded MCA was dissected and used for multiphoton laser-scanning microscopy. 
Key results. Our results provide direct observations for the first time of dynamic T cell 
behaviour in living brain tissue in real time and herein proved the feasibility of multiphoton 
laser-scanning microscopy for ex vivo live imaging of immune response after experimental 
stroke. 
Conclusions and Implications. It is hoped that these advances in imaging of immune cells 
will provide information that can be harnessed to a therapeutic advantage. 
 
Keywords. Inflammation, leukocytes, brain imaging, middle cerebral artery occlusion, stroke, 
multiphoton microscopy. 
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Introduction 
Leukocyte infiltration is a major mechanism contributing to the pathogenesis of cerebral 
ischaemic damage. However, the role of these immune cells in ischaemic damage still needs 
to be fully understood. Some intriguing proposals that lymphocytes may not be completely 
harmful for the brain or that manipulation of selected immune cells may result in a therapeutic 
advantage (Gee et al. 2006; Villoslada et al. 2008) need to be supported by a deep knowledge 
of the behaviour of these cells during the evolution of ischaemic damage and repair. 
Direct observation of dynamic cellular behaviour in living tissues has been facilitated by 
recent advances in multiphoton laser-scanning microscopy (MPLSM) (Zinselmeyer et al, 
2005; Schneider et al. 2006; Maffia et al. 2007; Millington et al. 2007; Cahalan et al.2008). 
MPLSM provides the ability to illuminate tissues at depth in the absence of significant 
phototoxicity, allowing analysis of physiological or pathological events over time and has 
been exploited to study T cells in the brain in experimental autoimmune encephalomyelitis 
(Flügel et al. 2007; Smorodchenko et al. 2007). We now report, for the first time, real time in 
situ imaging of T cell movement in brain tissue after a focal cerebral ischaemic insult. 
 
Methods 
All mice (6-8 weeks) were maintained on a 12/12 h light/dark cycle with free access to food 
and water at the Biological Procedures Unit, University of Strathclyde, in accordance with 
local ethical and UK Home Office regulations. Male C57BL6 mice (Harlan-Olac) were 
sacrificed (n=3) to obtain lymphocytes for adoptive transfer. A total of 2-5 X 10
6
 CFSE 
(Molecular Probe Inc.)-labelled lymphocytes from C57BL6 mice, prepared as previously 
described (Zinselmeyer et al. 2005; Schneider et al. 2006; Millington et al. 2007), were 
injected i.v. into age-matched C57BL6 recipients. Twenty four hours later, recipient animals 
were anaesthetised using 3% isoflurane anaesthesia in 100% O2 and maintained using 1.5-2% 
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isoflurane in 100% O2 as assessed by interdigital reflex. Mice were subjected to permanent 
left distal middle cerebral artery occlusion (MCAO) by electrocoagulation (Carswell et al. 
2005) (males, n=3) or sham surgery (female, n=1). Body temperature was maintained at 37°C 
throughout procedure. 
One female hCD2-GFP transgenic mouse that exhibits GFP-labelled T cells (de Boer et al. 
2003) with a very small proportion of GFP-labelled B cells (kindly gifted by Dr. Dimitris 
Kioussis, NIMR, London, UK) also underwent MCAO. 
At 24 or 48 hours post-MCAO, a sagittal brain slice (1500 µm thick) containing cortical 
branches of the occluded MCA (Fig. 1) was cut, using a Vibratome (Intracel, UK), in 
oxygenated artificial cerebrospinal fluid (ACSF, containing in mM: NaCl 124, KCl 3, 
NaHCO3 26, NaH2PO4 2.5, MgSO4 2, CaCl2 2 and D-Glucose 10 with 95% O2/5% CO2, 
pH~7.3) (Bushell et al. 2002), glued (Vetbond, 3M) onto a coverslip adhered to the bottom of 
the imaging chamber and continuously perfused with warmed (35-36°C), gassed (95% O2 and 
5% CO2) ACSF before and throughout imaging. Imaging was performed using a Radiance 
2000MP, MPLSM (Bio-Rad Laboratories Ltd, UK) as described previously (Zinselmeyer et 
al. 2005; Schneider et al. 2006; Maffia et al. 2007; Millington et al. 2007). The scans were 
made with 500 lps and between 256 x 256 pixel boxes, and acquired at 20 frames per min. 
Images were analysed using Volocity software (Improvision, UK). 
 
Results 
Initially brain slices were cut in ice-cold (< 4°C) sucrose solution as described previously 
(Bushell et al. 2002) and imaged at 35-36°C, however, lymphocytes observed in the 
parenchyma were stationary. This concurs with our own unpublished observations in 
lymph nodes. Hence, all slices included in the present study were prepared in room 
temperature ACSF. 
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Recruitment of labelled lymphocytes in the cerebrovasculature and in the cortex, 
downstream of occluded MCA in adoptive transfer mice, was observed at 24 hours and 48 
hours post- MCAO (Fig. 2A,B respectively). No cells were detectable in the sham-
operated mouse (data not shown). Furthermore, since CFSE will label all lymphocyte 
populations and not just T cells, using an hCD2 GFP transgenic mouse, we imaged, 
selectively, endogenous T cell movement in the brain at 48 hours post-MCAO (Figure 2C 
and the accompanying online movie). The average velocity of T cells was 9.4 µm/min 
although during the imaging period peak velocities approached 32 µm/min compared with 
average velocities in the region of 12-15 µm/min in lymph nodes previously reported 
(Zinselmeyer et al. 2005; Miller et al. 2002). 
 
Discussion and conclusion 
The presence of T lymphocytes has been previously described by immunohistochemistry at 1-
7 days post-MCAO (Li et al. 2005), but their role and behaviour in the parenchyma remains 
elusive. Our aim was not to quantify T cell recruitment after injury, but rather to provide a 
feasible protocol for cell detection in the living inflamed brain for future pharmacological 
targeting. We have proved the feasibility of MPLSM for in situ real time imaging of immune 
response after focal cerebral ischaemia. To the best of our knowledge this is the first 
demonstration of T cell movement in the brain after cerebral ischaemia and the first 
application of hCD2-GFP transgenic mice in cerebral ischaemia. Our results have three 
important implications. Firstly, our visualisation of T cells in the brain implies a dynamic role 
of T cells, possibly involving direct, physical contact with other cells. Secondly, the use of 
hCD2-GFP transgenic mice combined with MPLSM represents an important tool for 
investigating the temporal profile, role and behaviour of endogenous T cells during the 
evolution of ischaemic damage and repair. Finally, given the growing availability of 
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transgenic mice expressing fluorescently-labelled cell types (e.g. microglia), our use of 
adoptive lymphocyte transfer permits future investigations into cellular interactions thereby 
clarifying lymphocyte activity. 
One limitation of the current study is that immune cell mobility and activation could be 
drastically altered by the slice preparation, therefore the ultimate goal would be the in vivo 
imaging. In vivo imaging of immune response in the cortex with multiphoton microscopy has 
been possible so far only in autoimmune-type disease models, while the dynamic analysis of 
immune cells behaviour in murine stroke models in vivo until now has not been possible due 
to the technical limitations. A major obstacle is the paucity of immune cells infiltrating the 
ischaemic area compared with autoimmune disease and another hurdle is the difficulty to 
implant a cranial window enabling the imaging of the compromised area of interest. On the 
other hand, ex vivo real time imaging bypasses this issue allowing the imaging of the whole 
cortex, and therefore an easy detection of immune infiltrate. Furthermore, real time imaging 
of sagittal brain slices could easily allow the visualization of some other brain regions of 
interest (i.e. striatum, hippocampus) which could be affected by post-ischaemic inflammatory 
response (Wiart et al. 2007), and which cannot be visualized using conventional in vivo 
multiphoton imaging, due to depth limitation. 
For these reasons we strongly believe that our in situ real time imaging could represent the 
first important step towards the in vivo dynamic imaging of immune response after 
experimental stroke. Our advances in imaging techniques will help define and analyse the 
cellular interactions, role and behaviour of these immune cells in situ after stroke and will 
help us to understand how intervening in these cellular interactions will affect stroke 
pathology for future therapeutic exploitations.  
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Figure Legends 
Figure 1 
Representative images of the area of MPLSM imaging (white oval) containing the cortical 
branches of the occluded MCA (arrow) (A) and of a 1500 µm sagittal slice glued onto a 
coverslip for MPLSM imaging (B). 
Figure 2 
Three-dimensional reconstruction of lymphocyte infiltration in the cortex post-MCAO 
(A+B) At 24 hours post-MCAO fluorescently CFSE-labelled lymphocytes (green) were 
detectable in a cortical artery and only few cells were infiltrating the parenchyma (A). On the 
contrary, lymphocyte infiltration in the parenchyma is clearly detectable at 48 hours post-
MCAO (B). Each imaged volume consisted of 13 to 21 planes, 2.5 µm apart. Tracking of T 
cells in the cortex post-MCAO (C). At 48 hours post-MCAO endogenous hCD2-GFP T cells 
were clearly detectable in brain with tracking (yellow lines-red circle) shown in 6 consecutive 
snapshots representative of 9 minutes of imaging of the same field of view. Bar = 25 µm. The 
scans were acquired with 500 lps and between 256 x 256 pixel boxes, for a frame rate of 1.95 
fps. Images were analyzed using Volocity software (Improvision). The movie of T cells 
movement in the ischaemic brain tissue is also available as online supplemental data (movie1; 
view using Quick Time or Real Player). 
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